Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study.

Nickel C, Lahmann C, Tritt K, Muehlbacher M, Kaplan P, Kettler C, Krawczyk J, Loew TH, Rother WK, Nickel MK.

J Affect Disord. 2005 Aug;87(2-3):243-52.

PMID:
15985295
2.

Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study.

Muehlbacher M, Nickel MK, Kettler C, Tritt K, Lahmann C, Leiberich PK, Nickel C, Krawczyk J, Mitterlehner FO, Rother WK, Loew TH, Kaplan P.

Clin J Pain. 2006 Jul-Aug;22(6):526-31.

PMID:
16788338
3.

Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.

Nickel MK, Nickel C, Kaplan P, Lahmann C, Mühlbacher M, Tritt K, Krawczyk J, Leiberich PK, Rother WK, Loew TH.

Biol Psychiatry. 2005 Mar 1;57(5):495-9.

PMID:
15737664
4.

Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up.

Nickel MK, Loew TH.

Eur Psychiatry. 2008 Mar;23(2):115-7. Epub 2007 Nov 19.

PMID:
18024088
5.

Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.

Nickel MK, Nickel C, Mitterlehner FO, Tritt K, Lahmann C, Leiberich PK, Rother WK, Loew TH.

J Clin Psychiatry. 2004 Nov;65(11):1515-9.

PMID:
15554765
6.

Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial.

Nickel C, Tritt K, Muehlbacher M, Pedrosa Gil F, Mitterlehner FO, Kaplan P, Lahmann C, Leiberich PK, Krawczyk J, Kettler C, Rother WK, Loew TH, Nickel MK.

Int J Eat Disord. 2005 Dec;38(4):295-300.

PMID:
16231337
7.

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study.

McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH.

Bipolar Disord. 2002 Jun;4(3):207-13.

PMID:
12180276
8.

Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.

Mowla A, Kardeh E.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):970-3. doi: 10.1016/j.pnpbp.2011.01.016. Epub 2011 Feb 1.

PMID:
21291943
9.

Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.

Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J; CAPSS-277 Investigator Group.

Clin Ther. 2009 Mar;31(3):542-59. doi: 10.1016/j.clinthera.2009.03.020.

PMID:
19393844
10.

Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study.

Tritt K, Nickel C, Lahmann C, Leiberich PK, Rother WK, Loew TH, Nickel MK.

J Psychopharmacol. 2005 May;19(3):287-91.

PMID:
15888514
11.

Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study.

Loew TH, Nickel MK, Muehlbacher M, Kaplan P, Nickel C, Kettler C, Fartacek R, Lahmann C, Buschmann W, Tritt K, Bachler E, Mitterlehner F, Pedrosa Gil F, Leiberich P, Rother WK, Egger C.

J Clin Psychopharmacol. 2006 Feb;26(1):61-6.

PMID:
16415708
12.

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group.

Cephalalgia. 2007 Jul;27(7):814-23. Epub 2007 Apr 18. Erratum in: Cephalalgia. 2007 Aug;27(8):962.

PMID:
17441971
13.

The impact of topiramate on health-related quality of life indicators in chronic migraine.

Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.

Headache. 2007 Nov-Dec;47(10):1398-408.

PMID:
18052949
14.

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.

Arthritis Rheum. 2004 Sep;50(9):2974-84.

15.

Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.

Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.

Clin Ther. 2006 Jul;28(7):1002-11. Erratum in: Clin Ther. 2006 Sep;28(9):1482.

PMID:
16990078
16.

Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.

Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.

Headache. 2009 Sep;49(8):1153-62. doi: 10.1111/j.1526-4610.2009.01508.x.

PMID:
19719543
17.

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.

Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.

Health Qual Life Outcomes. 2007 Oct 4;5:56.

18.

A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.

Roy Chengappa K, Kupfer DJ, Parepally H, John V, Basu R, Buttenfield J, Schlicht P, Houck P, Brar JS, Gershon S.

Bipolar Disord. 2007 Sep;9(6):609-17.

PMID:
17845276
19.

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J; Topiramate Chronic Migraine Study Group.

Headache. 2007 Feb;47(2):170-80.

PMID:
17300356
20.

A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.

Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.

J Clin Psychiatry. 2011 Oct;72(10):1405-12. doi: 10.4088/JCP.09m05355gre.

PMID:
21367355

Supplemental Content

Support Center